Component

N-Methyl-D-aspartate

Context-specific entity; species, compartment and exposure are stated on each claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Human DDO-1 also oxidized N-methyl-D-aspartate, with reported Km 6.8 mM and kcat 37.7 per second.

    Human D-aspartate oxidase / DDO → N-Methyl-D-aspartate source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Purified recombinant human DDO-1.
    limitations
    Does not establish endogenous NMDA synthesis or justify conflating NMDA with D-aspartate.
    nutrient_topic
    D-Aspartate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · D-Aspartate
    plain_language
    The enzyme accepts a related chemical that is distinct from the NMDA receptor.
    primary_references
    Structural and functional characterization of the human brain D-aspartate oxidase. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9163533/ · DOI 10.1093/oxfordjournals.jbchem.a021655

    D-Aspartate: synthesis, clearance, neural and endocrine mechanisms (2026-09-19) · lines 80–86

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified recombinant human DDO-1. · source_derived_draft · unverified_draft

    ## d-aspartate-human-ddo-nmda The enzyme accepts a related chemical that is distinct from the NMDA receptor. Human DDO-1 also oxidized N-methyl-D-aspartate, with reported Km 6.8 mM and kcat 37.7 per second. Model: Purified recombinant human DDO-1. Limitations: Does not establish endogenous NMDA synthesis or justify conflating NMDA with D-aspartate. Evidence access: Primary abstract Structural and functional characterization of the human brain D-aspartate oxidase. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9163533/ · DOI 10.1093/oxfordjournals.jbchem.a021655
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Porcine DDO showed substrate activation above approximately 0.2 mM D-aspartate; N-methyl-D-aspartate instead produced substrate inhibition.

    D-Aspartate → Porcine D-aspartate oxidase / DDO source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Purified porcine enzyme concentration-response assays.
    limitations
    Do not extrapolate assay thresholds to dietary dosing.
    nutrient_topic
    D-Aspartate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · D-Aspartate
    plain_language
    Different substrates change the enzyme kinetics differently.
    primary_references
    Functional and structural characterization of D-aspartate oxidase from porcine kidney: non-Michaelis kinetics due to substrate activation. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17234685/ · DOI 10.1093/jb/mvm041

    D-Aspartate: synthesis, clearance, neural and endocrine mechanisms (2026-09-19) · lines 120–126

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified porcine enzyme concentration-response assays. · source_derived_draft · unverified_draft

    ## d-aspartate-ddo-substrate-activation Different substrates change the enzyme kinetics differently. Porcine DDO showed substrate activation above approximately 0.2 mM D-aspartate; N-methyl-D-aspartate instead produced substrate inhibition. Model: Purified porcine enzyme concentration-response assays. Limitations: Do not extrapolate assay thresholds to dietary dosing. Evidence access: Primary abstract Functional and structural characterization of D-aspartate oxidase from porcine kidney: non-Michaelis kinetics due to substrate activation. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17234685/ · DOI 10.1093/jb/mvm041
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards